Prot# NCI R03L1: A Phase 2 Study of OSI 774 (IND# 63383) in Combination with Celecoxib (Celebrex, Pharmacia) as Second-Line Therapy in Advanced Non-Small Cell Lung Cancer (NCI prot# 5416) (Rush prot# Lung 2002-1)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/22/04 → 1/1/08

Funding

  • Rush University Medical Center (PRESPENDING // PRESPENDING)
  • Pfizer Inc. (PRESPENDING // PRESPENDING)